Netupitant/palonosetron (Akynzeo®)
Akynzeo® is indicated for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy and for prevention of acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
Rapid Review
Commenced | Completed | Outcome |
26/08/2015 | 13/10/2015 | Full Pharmacoeconomic Evaluation Not Recommended |